La Rosée P - Search Results

1

Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis.

Knauft J, Schenk T, Ernst T, Schnetzke U, Hochhaus A, La Rosée P, Birndt S. Knauft J, et al. Among authors: la rosee p. Leukemia. 2024 Feb;38(2):235-249. doi: 10.1038/s41375-024-02135-8. Epub 2024 Jan 18. Leukemia. 2024. PMID: 38238443 Free PMC article. Review.

2

Imatinib therapy in chronic myelogenous leukemia: strategies to avoid and overcome resistance.

Hochhaus A, La Rosée P. Hochhaus A, et al. Among authors: la rosee p. Leukemia. 2004 Aug;18(8):1321-31. doi: 10.1038/sj.leu.2403426. Leukemia. 2004. PMID: 15215876 Review.

3

Omacetaxine mepesuccinate prevents cytokine-dependent resistance to nilotinib in vitro: potential role of the common β-subunit c of cytokine receptors.

Klag T, Härtel N, Erben P, Schwaab J, Schnetzke U, Schenk T, Hochhaus A, La Rosée P. Klag T, et al. Among authors: la rosee p. Leukemia. 2012 Jun;26(6):1321-8. doi: 10.1038/leu.2011.380. Epub 2012 Jan 13. Leukemia. 2012. PMID: 22289991

4

Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry.

Birndt S, Schenk T, Heinevetter B, Brunkhorst FM, Maschmeyer G, Rothmann F, Weber T, Müller M, Panse J, Penack O, Schroers R, Braess J, Frickhofen N, Ehl S, Janka G, Lehmberg K, Pletz MW, Hochhaus A, Ernst T, La Rosée P. Birndt S, et al. Among authors: la rosee p. J Cancer Res Clin Oncol. 2020 Apr;146(4):1065-1077. doi: 10.1007/s00432-020-03139-4. Epub 2020 Feb 20. J Cancer Res Clin Oncol. 2020. PMID: 32076823 Free PMC article.

5

The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation.

La Rosée F, Bremer HC, Gehrke I, Kehr A, Hochhaus A, Birndt S, Fellhauer M, Henkes M, Kumle B, Russo SG, La Rosée P. La Rosée F, et al. Among authors: la rosee p. Leukemia. 2020 Jul;34(7):1805-1815. doi: 10.1038/s41375-020-0891-0. Epub 2020 Jun 9. Leukemia. 2020. PMID: 32518419 Free PMC article.

6

The JAK1/2 inhibitor ruxolitinib in patients with COVID-19 triggered hyperinflammation: the RuxCoFlam trial.

Hammersen J, Birndt S, Döhner K, Reuken P, Stallmach A, Sauerbrey P, La Rosée F, Pfirrmann M, Fabisch C, Weiss M, Träger K, Bremer H, Russo S, Illerhaus G, Drömann D, Schneider S, La Rosée P, Hochhaus A. Hammersen J, et al. Among authors: la rosee p. Leukemia. 2023 Sep;37(9):1879-1886. doi: 10.1038/s41375-023-01979-w. Epub 2023 Jul 28. Leukemia. 2023. PMID: 37507425 Free PMC article.

7

Molecular pathogenesis of tyrosine kinase resistance in chronic myeloid leukemia.

La Rosée P, Hochhaus A. La Rosée P, et al. Curr Opin Hematol. 2010 Mar;17(2):91-6. doi: 10.1097/MOH.0b013e3283366be1. Curr Opin Hematol. 2010. PMID: 20071983 Review.

8

Imatinib and beyond--targeting activated tyrosine kinases in myeloproliferative disorders.

Hochhaus A, Reiter A, Ernst T, La Rosée P. Hochhaus A, et al. Among authors: la rosee p. Onkologie. 2012;35 Suppl 1:34-41. doi: 10.1159/000334824. Epub 2012 Jan 20. Onkologie. 2012. PMID: 22286586

9

[Hemophagocytic lymphohistiocytosis in adults].

Schenk T, La Rosée P. Schenk T, et al. Among authors: la rosee p. Dtsch Med Wochenschr. 2016 Aug;141(16):1141-3. doi: 10.1055/s-0042-107376. Epub 2016 Aug 10. Dtsch Med Wochenschr. 2016. PMID: 27509340 German.

10

[Hemophagocytic lymphohistiocytosis : A diagnostic challenge on the ICU].

Lachmann G, La Rosée P, Schenk T, Brunkhorst FM, Spies C. Lachmann G, et al. Among authors: la rosee p. Anaesthesist. 2016 Oct;65(10):776-786. doi: 10.1007/s00101-016-0216-x. Anaesthesist. 2016. PMID: 27612865 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page